+
Site Tour

LAAO Summit 2025 | Post-procedural pharma D. Arzamendi

14th Annual International Left Atrial Appendage Occlusion (LAAO) Summit - Post-procedural pharma: How low can you go? By Dabit Arzamendi

LEARN MORE:

LAAO Summit 2025

Related Videos

Clot or not K. Piayda

Live Case K. Kaczmarek

Next generation Amulet LAAO X.Freixa

Prediction and planning in practice M. Bergmanm

Debate: Concomitant PFA & LAAO M. Gunawardene & T.Zeus

Case Transmission | Tricuspid focus

LAAO Summit 2022: The big dilemma 2

Premiclose 2022: Midterm evolution of PDA closure

PCR LV 2021: Navitor™

Case Parade | Mitral focus

Review the Trends | Tricuspid focus

Echo course ASD

TRENDING TOPICS

HFA Tutorials 2025 I.Stankovic

HFA Tutorials 2025
STRAIN and echo workshop | How to assess an HF patient

HFA Tutorial 2025 E.Donal | Case based

HFA Tutorials 2025
Case based | How to manage a Secondary AV valve disease, with a focus on Tricuspid

HFA Tutorials 2025 E.Donal

HFA Tutorials 2025
Simulation & Hands-on | How to treat an HF patient with the TEER therapy

CONNEXT


HUB
RELATED RESOURCES

Amplatzer™ Amulet™ LAA Occluder

Data Summary PFO closure in patients > 60 Years

PCR LV 2021: Navitor™ Live-in-a-box

LAAO Neuro Brochure

CONNEXT


LIVE
RELATED EVENTS

LAAO Summit 2023: Anatomy & imaging – The future

AV Valves Summit 2024 | Closing of Day 2

LAAO Summit 2023: Leaks

Case Parade | Tricuspid focus

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline